These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2989070)

  • 1. [Effects of a tamoxifen-norethisterone combination in 16 patients with hepatocellular carcinoma].
    Trinchet JC; Roudil F; Vaysse J; Beaugrand M
    Gastroenterol Clin Biol; 1985 May; 9(5):455-6. PubMed ID: 2989070
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma.
    Clerici C; Castellani D; Russo G; Fiorucci S; Sabatino G; Giuliano V; Gentili G; Morelli O; Raffo P; Baldoni M; Morelli A; Toma S
    Anticancer Res; 2004; 24(2C):1255-60. PubMed ID: 15154656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma.
    Lu YS; Hsu C; Li CC; Kuo SH; Yeh KH; Yang CH; Hsu CH; Wu CY; Cheng AL
    Hepatogastroenterology; 2004; 51(57):815-9. PubMed ID: 15143923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hepatocellular carcinoma with tamoxifen].
    Paliard P; Clément G; Saez S; Chabal J; Partensky C
    Gastroenterol Clin Biol; 1984; 8(8-9):680-1. PubMed ID: 6092188
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma.
    Elba S; Giannuzzi V; Misciagna G; Manghisi OG
    Ital J Gastroenterol; 1994 Mar; 26(2):66-8. PubMed ID: 8032079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Randomized trial of elliptinium acetate and tamoxifen in the treatment of inoperable hepatocellular carcinoma].
    Jouanolle H; Delamaire D; Deugnier Y; Lhéry D; Simon M; Brissot P; Bourel M
    Gastroenterol Clin Biol; 1986 Feb; 10(2):185-7. PubMed ID: 3009255
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma.
    Cheng AL; Yeh KH; Fine RL; Chuang SE; Yang CH; Wang LH; Chen DS
    Hepatogastroenterology; 1998; 45(24):1955-60. PubMed ID: 9951847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
    Pan DY; Qiao JG; Chen JW; Huo YC; Zhou YK; Shi HA
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):211-5. PubMed ID: 14599971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature].
    Macaigne G; Auriault ML; Boivin JF; Cheaib S; Chayette C; Deplus R
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1165-7. PubMed ID: 12520204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.
    Chow PK; Tai BC; Tan CK; Machin D; Win KM; Johnson PJ; Soo KC;
    Hepatology; 2002 Nov; 36(5):1221-6. PubMed ID: 12395333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.
    Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
    Hepatology; 2004 Dec; 40(6):1361-9. PubMed ID: 15565568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic oral etoposide and tamoxifen in the treatment of far-advanced hepatocellular carcinoma.
    Cheng AL; Chen YC; Yeh KH; Chuang SE; Chen BR; Chen DS
    Cancer; 1996 Mar; 77(5):872-7. PubMed ID: 8608477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma.
    Gallo C; De Maio E; Di Maio M; Signoriello G; Daniele B; Pignata S; Annunziata A; Perrone F;
    BMC Cancer; 2006 Jul; 6():196. PubMed ID: 16863588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial.
    Manesis EK; Giannoulis G; Zoumboulis P; Vafiadou I; Hadziyannis SJ
    Hepatology; 1995 Jun; 21(6):1535-42. PubMed ID: 7768497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does anti-estrogen therapy after estrogen receptor analysis have value in palliative therapy of hepatocellular carcinoma?].
    Kreysel C; Porschen R
    Z Gastroenterol; 1998 Jul; 36(7):605-7. PubMed ID: 9738309
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
    Barbare JC; Bouché O; Bonnetain F; Raoul JL; Rougier P; Abergel A; Boige V; Denis B; Blanchi A; Pariente A; Milan C; Bedenne L
    J Clin Oncol; 2005 Jul; 23(19):4338-46. PubMed ID: 15994145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy for hepatocellular carcinoma].
    Okusaka T; Ueno H; Ikeda M
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2122-8. PubMed ID: 15628756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of hepatocellular carcinoma with tamoxifen].
    Raoul JL
    Gastroenterol Clin Biol; 1996 Mar; 20(2):221-2. PubMed ID: 8761695
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tamoxifen and hepatocellular carcinoma: verdict after enthusiasm...].
    Barbare JC
    Gastroenterol Clin Biol; 1996; 20(6-7):609-10. PubMed ID: 8881581
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study.
    Liu CL; Fan ST; Ng IO; Lo CM; Poon RT; Wong J
    Am J Gastroenterol; 2000 Jan; 95(1):218-22. PubMed ID: 10638587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.